SEC 13F Intelligence

Syquant Capital Sas / IMMU

Syquant Capital Sas’s Immunomedics Inc Position

Does Syquant Capital Sas own Immunomedics Inc (IMMU)? Not currently — the last reported position was 267.9K shares worth $23M in Q3 2020; the fund’s latest 13F (Q2 2026) no longer reports it.

Position Value
$23M
Q3 2020
Shares
267.9K
% of Portfolio
+11.60%
Quarters Held
1
position exited

Position History IMMU

Reported value by quarter
Q3 ’20: $23MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020267.9K$23M+11.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Syquant Capital Sas’s full portfolio or all institutional holders of IMMU.